 multimod therapi manag primari nonmetastat ewe sarcoma bone long-term follow-up first intergroup studi total elig children first intergroup ewe sarcoma studi iess may novemb group institut patient treatment radiotherapi primari lesion cyclophosphamid vincristin dactinomycin adriamycin doxorubicin adria columbu OH vac adr treatment treatment adr group II institut patient treatment treatment treatment bilater pulmonari radiotherapi vac bpr percentag patient relapse-fre rf year treatment strong statist evid signific advantag rf treatment vac adr versu vac treatment versu similar signific result respect overal surviv patient diseas pelvic site surviv year diseas nonpelv site pelvic case evid surviv treatment nonpelv case strong evid surviv treatment overal percentag patient metastat diseas percentag treatment overal incid local recurr evid local recurr rate treatment patient characterist prognosi respect rf overal surviv experi primari site nonpelv patient favor patient age patient favor